The Wnt genes encode a large family of secreted proteins that play a key role in embryonic development and tissue differentiation in many species (Rijsewijk et al
Results and discussion
In situ hybridization and immunohistochemical experiments were performed on mouse embryo tissue sections. By 8.5 d.p.c., sFRP-1 mRNA and protein were weakly detected in the tubular heart in the endocardium and myocardium; the pericardium remained negative (data not shown). At 9.5 d.p.c., in serial sagittal sections, sFRP-1 transcripts and protein were detected in the common ventricular and atrial chamber of the developing heart, in the aortic sac, and in the sinus venosus but not in the pericardium (Fig. 1A,B,D) . The inner endothelial cells making up the endocardium did not express sFRP-1. By 11.5 d.p.c., heart morphogenesis has advanced to the point that the forming chambers of the mature structure are readily discernible, the heart is four-chambered, beats productively and has clearly delineated ventricles and atria. On serial sagittal sections from 11.5 and 12.5 d.p.c. embryos, the trabeculated wall of the ventricular chamber of the heart along with the wall of the atrial chamber showed a high level of sFRP-1 (Fig. 1E,F,H±J) . The presence of sFRP-1 was also observed in the muscular part of the interventricular septum, whereas there was no detectable signal in the endocardial cushion (Fig. 1I,J) . Again, transcript (Fig. 1E,I ) and protein (Fig. 1F ,J) expression patterns overlapped. Interestingly, sFRP-1 expression in the heart was transitory, and by 14.5 d.p.c. the expression level had decreased dramatically. Sagittal section labeling from a 17.5 d.p.c. embryo revealed a weak expression of sFRP-1 transcripts in the heart (Fig. 1M,N) . From 9.5 to 11.5 d.p.c., sFRP-1 transcripts in the visceral yolk sac were con®ned to the inner lining endothelial cell layer (Fig. 2A) ; at 12.5 d.p.c., a slight labeling was maintained (Fig. 2B ) but at 14.5 d.p.c., no expression was found (not shown). The aorta remained negative during the course of mouse development.
FrzA might function as a soluble Wnt-binding protein. Since FrzA has been reported to interact with Wg or Wingless (a Drosophila Wnt-1 homologue) in vitro and to inhibit the activities of Xwnt8 and human Wnt2 in Xenopus embryo (Xu et al., 1998) , we searched whether sFRP-1 expression overlapped with that of its putative Wnt ligands. mWnt-1 was not present in the heart during the development and mWnt2 was expressed only in the pericardium where it might not interact directly with sFRP-1 (our data; McMahon and McMahon, 1989; McMahon and Bradley, 1990) .
Examination of mWnt-8 transcripts during embryogenesis, provided new insights into the expression of mWnt-8 which was cloned recently (Bouillet et al., 1996) . In accordance with the initial study, we report a low abundance of mWnt-8 transcripts during embryogenesis. In the mouse embryogenesis study of Bouillet et al., the last stage of detection of mWnt-8 transcripts by in situ hybridization and RT-PCR was between 8.5 and 9.5 d.p.c., respectively. The expression was restricted to domains corresponding to the putative fourth rhombomere and the caudal region of the neural plate (Bouillet et al., 1996) . Here, we described that mWnt-8 RNA continues to be expressed later and in other distinct structures during embryogenesis in particular an unexpected presence in the myocardium. mWnt-8 transcripts detected after RT-PCR ampli®cation, peaked at 10.5 d.p.c. and decreased thereafter with a slight expression from 14.5 to 17.5 d.p.c. (Fig.  3A) . In situ analysis revealed that mWnt-8 and sFRP-1 exhibit identical temporal and spatial patterns of gene expression within the developing heart. From 9.5 to 12.5 d.p.c., mWnt-8 transcripts are limited to the myocardium and rapidly decrease to be undetectable at 14.5 d.p.c. (Fig.  1C ,G,K,L,O). Moreover RT-PCR and in situ hybridization reveal mWnt-8 mRNA presence in adult tissues in which no expression had been reported before (Bouillet et al., 1996) . The highest mWnt-8 mRNA expression is observed in the kidney and in the liver, with lower expression in several other tissues including the heart (Fig. 3B) . In situ hybridization revealed that in aorta, endothelial and smooth muscle cells were positive for sFRP-1 (Fig. 4A) but not for mWnt-8 transcripts (Fig. 4C) and that in the heart, cardiac myocytes exhibited sFRP-1 expression (Fig. 4B ) but we did not detect any mWnt-8 speci®c cardiac labeling (Fig. 4D) . Fig. 1 . Coexpression analysis of sFRP-1 and mWnt-8 in embryonic heart of embryo from 9.5 (A±D), 11.5 (E±G), 12.5 (H±L) and 17.5 (M±O). I and K are, respectively, the heart structure part of H and L. sFRP-1 and mWnt-8 transcripts were detected respectively with a digoxigenin-labelled sFRP-1 (A,E,H,I,M) or mWnt-8 antisense probe (C,G,K,L,O) and revealed by blue staining. Sections were then counterstained with a nuclear green stain. sFRP-1 protein expression was detected by immunohistochemistry labeling (brown color) (B,D,F,J,N). mWnt-8 transcript expression overlapped with sFRP-1 transcripts and protein expression in the heart. sFRP-1 and mWnt-8 were detected in the wall of the aortic sac (AS), of the sinus venosus (SV) and in the trabeculated wall of the common ventricular heart chamber (V), in the muscular part of the interventricular septum (is) and in the wall of the common atrial chamber atrium (A), but not in the endocardial cushions (ec). sFRP-1 and mWnt-8 are highly expressed in the myocardium (m) from 9.5 to 12.5 d.p.c. but their expression decreased to be undetectable at 17.5 d.p.c. in the heart. No expression was observed in the pericardium (p) or the endocardium (arrow). Magni®cations £ 40 (A±C), £ 10 (D± G), £ 4 (H±L), £ 5 (M±O).
In order to test the ability of FrzA to bind mWnt-8, we cotransfected COS-7 cells with FrzA-myc::his and mWnt-8-V5::his expression plasmids. Total cell lysates were immunoprecipitated with V5-speci®c antibody or with control mouse IgG. Subsequent western with myc and V5 monoclonal antibodies showed that FrzA-myc::his associates with mWnt-8-V5::his in the immune complexes (Fig. 5) . Transiently tranfected mWnt-8-V5::his and FrzA-Myc::his are ef®ciently secreted, but a large part of protein remains attached to the membrane and releases by heparin treatment (our data; Dupla Áa et al., 1999; Hsieh et al., 1999) . Additional controls to assess the speci®city of myc and V5 antibody were realized from cell lysates containing either FrzAmyc::his alone or mWnt-8-V5::his alone (Fig. 5) .
In summary, we have found that sFRP-1 and its potential ligand mWnt-8 have a striking pattern of expression in the developing heart, and we speculate that their interaction may be involved in controlling heart maturation. Further studies involving ablation of endogenous sFRP-1 or overexpression will be required to substantiate this hypothesis.
Experimental procedures

Mouse embryos and adult tissues
Inbred lines of C57BL/6J mice were mated and the morning of vaginal plug was counted as post coital (p.c.) day 0.5. Pregnant females were anaesthetized by CO 2 and sacri®ced by cervical dislocation. Whole embryos or extraembryonic membranes were removed from surrounding tissue in cold phosphate buffered saline (PBS) and immediately frozen in liquid nitrogen, for RNA extraction. For in situ hybridization and immunohistochemistry analysis, embryos were carefully transferred to a solution of 4% paraformaldehyde in PBS. After an overnight ®xation, the embryos were dehydrated and embedded in paraf®n. Freshly dissected adult mouse tissues were processed as previously described for embryo tissues for in situ hybridization and immunohistochemistry analysis (Dupla Áa et al., 1999) .
In situ hybridization analysis
Antisense riboprobe for in situ hybridization were prepared from pGEM-T (Invitrogen) plasmid containing a 183-bp (bp 772±954) or a 464 bp (bp 2076±2539) RT-PCR ampli®ed fragment corresponding respectively to the open reading frame or to the 3 H -untranslated region of sFRP-1 (Rattner et al., 1997). mWnt-8, mWnt-1 and mWnt-2 cRNA probes were synthesized from plasmids kindly provided by Dr. A. McMahon (Roche Institute of Molecular Biology, NJ, USA). cRNA probes were labeled using digoxigenin-11-UTP using Genius Labeling and in situ hybridization was carried out on serial 5 mm sections of whole embryos and adult mouse tissues ®xed in 4% paraformaldehyde using Detection Kit (Boehringer Mannheim, Germany) as previously described (Dupla Áa et al., 1999) . Sections were counterstained with the nuclear stain methyl green (Vector). At least three whole embryos by timepoint were completely analyzed.
Immunohistochemistry analysis
Rabbit antisera used for sFRP-1 protein detection were produced from two oligopeptides corresponding to C-terminal amino acids 206±218 and 269±296 of FrzA by Research Genetics, Inc. (Huntsville, AL), as previously described (Dupla Áa et al., 1999) .
Sections (5 mm) were cut from paraformaldehyde-®xed tissue. Endogenous peroxidase was neutralized with H 2 O 2 and followed by incubation with the primary antibody. Sections were then visualized by immunoperoxidase staining protocol as described (Dupla Áa et al., 1999) . Sections were counterstained with 10% Gill hematoxylin. For each tissue section labeled with FrzA antibody, a negative control was prepared by staining a serially cut section with a serum from pre-immune rabbit. The two anti-peptide polyclonal antisera yielded similar staining patterns on different mouse adult and fetal tissues.
Co-immunoprecipitation experiments
For protein analysis, expression vector were constructed. The full coding sequence of FrzA was fused in C terminal with a myc::his epitope into pcDNA3.1/Myc-His vector (Invitrogen) and the entire coding sequence of mouse Wnt-8 (a generous gift from Dr. P. Chambon; Bouillet et al., 1996) was fused in C terminal with a V5-His epitope into pcDNA 3.1/V5-His plasmid (Invitrogen). COS-7 cells were transiently transfected with 8 mg expression vector per 10 cm dish, using Superfect reagent (Qiagen) according to the manufacturer's protocol. Cells were lysed in lysis buffer (50 mM Tris (pH 7:5), NP40 1%, deoxycholate 0.5%, SDS 0.1%) and the insoluble pellet discarded after centrifugation at 10 000 rev./min. The protein concentration in the soluble fraction was calculated with BCA method (Pierce). Equal protein amounts of the soluble fraction were immunoprecipitated with anti-V5 (Invitrogen) antibodies or with Ig G1 antibody control during 3 h. Immune complexes were immobilized overnight on protein A/G PLUS-Agarose (Santa Cruz Biotechnology, Inc.). The beads were washed three times and the bound proteins were eluted by boiling, in SDS-sample buffer. Proteins were separated on SDS-polyacrylamide gels, transferred to PVDF membranes (Millipore), and western-blotted with antibodies. Bound antibodies were visualized with horseradish-peroxidase-conjugated anti-mouse IgG using the Enhanced Chemiluminescence (ECL) Western Blotting System (Amersham). Sections of paraf®n-embedded aorta, heart were hybridized with a digoxigenin-labelled sFRP-1 antisense probe (A,B) , or mWnt-8 antisense probe (C,D). sFRP-1 was expressed in the media (m) and endothelium (e) from mouse aorta (A) and in the myocytes (cm) of mouse adult heart (B). l, lumen. Magni®cation £ 40 (A±D).
